Skip to content

Repère Santé

Active
Non-profit associationfounded 20233 yrs activeAvenue de Ninove,Jemelle 11, 5580 Rochefort, BelgiumKBO/BCE: BE 0804.242.242
Summary

Repère Santé has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€171,174) and a net result of -€72,267. Its solvency ranks better than 5% of 646 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Checked score

Score 2025
44 / 100
Weak
Negative equity caps the score. Every signal that weighs is under Signals.
Axes
Profitability8
Solvency5
Growth-
Track record79
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.91; short-term debt: 57.3% of total assets), and equity is negative.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 3 years 0 10 y
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
-20.3%
Return on assets
-8.6%
Age of the figures
9 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-04-2026, 102 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
102 d early
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 5 July 2023, Repère Santé was incorporated as a Non-profit association.1 Of the 2 current board members, Elisabeth Lysy has served longest, since 2026.2 The company has filed annual accounts once, for fiscal year 2025.3

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 08-06-2026
  3. 3National Bank, annual accounts 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€72,267
Working capital
-€45,075
Balance-sheet composition
Assets €842,449
Fixed assets €405,075
Current assets €437,374
Equity and liabilities
Equity-€171,174
Debt€1.0m
Equity is negative: debt (€1.0m) exceeds the balance-sheet total (€842,449).
Key figures and ratios
2025 value
EBITDA
-€24,034
Cash flow
-€49,781
Solvency
-20.3%
Current ratio
0.91
ROA
-8.6%
Interest coverage
-0.93
Debt
€1.0m
Debt ≤ 1 year
€482,449
Debt > 1 year
€530,805
Staff costs
€923,468
No debt to equity: equity is negative, so debt divided by equity means nothing.

Peer companies

Historical observation

Of the 1,251 companies that looked in July 2024 the way this one looks now, 1.0% went bankrupt within 24 months and 97% are still going.

  • Small
  • 2 to 5 years old
  • negative equity
  • a small loss
1.0% went bankrupt
2.2% stopped otherwise
97% still going

A further 0.2% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 1,251 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 45 lines
Balance sheet Code2025
Assets
Total assets20/58€842,449
Fixed assets21/28€405,075
Intangible fixed assets21€34,312
Tangible fixed assets22/27€365,663
Land and buildings22€363,059
Plant, machinery and equipment23€359
Furniture and vehicles24€2,245
Financial fixed assets28€5,100
Current assets29/58€437,374
Amounts receivable within one year40/41€427,142
Trade receivables40€18,021
Other amounts receivable41€409,121
Deferred charges and accrued income490/1€10,232
Equity and liabilities
Total equity and liabilities10/49€842,449
Equity10/15-€171,174
Profit (loss) carried forward14-€292,007
Investment grants15€120,833
Amounts payable17/49€1.0m
Amounts payable after more than one year17€530,805
Financial debts170/4€530,805
Amounts payable within one year42/48€482,449
Financial debts43€314,131
Credit institutions430/8€250,131
Other loans439€64,000
Trade debts44€4,656
Suppliers440/4€4,656
Taxes, remuneration and social security45€162,954
Taxes450/3€25,253
Remuneration and social security454/9€137,701
Accrued charges and deferred income492/3€369
Income statement Code2025
Remuneration, social security and pensions62€923,468
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€22,486
Other operating charges640/8€2
Gross operating margin9900€899,436
Operating profit (loss)9901-€46,520
Financial income75/76B€5
Recurring financial income75€5
Financial charges65/66B€25,752
Recurring financial charges65€25,752
Profit (loss) for the period before taxes9903-€72,267
Profit (loss) for the period9904-€72,267
Profit (loss) for the period to be appropriated9905-€72,267
Appropriation of the result
Profit (loss) to be appropriated9906-€292,007
Profit (loss) brought forward from the previous period14P-€219,740
Social balance
Average headcount (FTE)908710.3

The notes to these accounts (16 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Remuneration, social security and pensions62€923,468
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€22,486
Other operating charges640/8€2
Gross operating margin9900€899,436
Operating profit (loss)9901-€46,520
Financial income75/76B€5
Recurring financial income75€5
Financial charges65/66B€25,752
Recurring financial charges65€25,752
Profit (loss) for the period before taxes9903-€72,267
Profit (loss) for the period9904-€72,267
Profit (loss) for the period to be appropriated9905-€72,267
Line2025
Assets
Total assets20/58€842,449
Fixed assets21/28€405,075
Intangible fixed assets21€34,312
Tangible fixed assets22/27€365,663
Land and buildings22€363,059
Plant, machinery and equipment23€359
Furniture and vehicles24€2,245
Financial fixed assets28€5,100
Current assets29/58€437,374
Amounts receivable within one year40/41€427,142
Trade receivables40€18,021
Other amounts receivable41€409,121
Deferred charges and accrued income490/1€10,232
Equity and liabilities
Total equity and liabilities10/49€842,449
Equity10/15-€171,174
Profit (loss) carried forward14-€292,007
Investment grants15€120,833
Amounts payable17/49€1.0m
Amounts payable after more than one year17€530,805
Financial debts170/4€530,805
Amounts payable within one year42/48€482,449
Financial debts43€314,131
Credit institutions430/8€250,131
Other loans439€64,000
Trade debts44€4,656
Suppliers440/4€4,656
Taxes, remuneration and social security45€162,954
Taxes450/3€25,253
Remuneration and social security454/9€137,701
Accrued charges and deferred income492/3€369
Line2025
Profit (loss) for the period9904-€72,267
+ Depreciation and write-downs630€22,486
Operating cash flow (approximation)-€49,781

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
08-06
State Gazette act Resignations: Laure Debucquois (director) and Françoise Milcamp (director)
Appointments: Elisabeth Lysy (director) and Oriane De Vleeschouwer (director)5 facts ▸
  • General meeting, 31-03-2026
  • Director resignation, Laure Debucquois (director)
  • Director resignation, Françoise Milcamp (director)
  • Director appointment, Elisabeth Lysy (director)
  • Director appointment, Oriane De Vleeschouwer (director)
20-04
NBB filing Annual accounts filed
fiscal year 2025 · full schema
State Gazette actNBB filing
1 of 3 acts read
About the unread acts

Of the 3 Belgian State Gazette acts we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
2 directors, last change in 2026
Elisabeth Lysy
Director · since 08-06-2026
Current
Oriane De Vleeschouwer
Director · since 08-06-2026
Current
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
2 of this company's 3 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Rochefort · 1 establishment unit since 2024
seat establishment The establishment unit on the map
Ground area
1,269 m²
Building footprint
25 m²
Parcel 91075A0184/00R005, Wallonia. Linked by address, not a title deed.
1 establishment unit
Avenue de Ninove,Jemelle 11, 5580 Rochefort
General medical practice
since 20242.351.578.621
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
91075A0184/00R005 Wallonia 1,269 m² 1 · 25 m² -
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Mandate history

4 people since 2026, 2 in office
Show
  • Board
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
Elisabeth Lysy
  • Director, from 08-06-2026 to date
Oriane De Vleeschouwer
  • Director, from 08-06-2026 to date
Françoise Milcamp
  • Director, until 08-06-2026
Laure Debucquois
  • Director, until 08-06-2026
See the board, name and seat on a given date →

Structure & network

Connections & network

2 current directors
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, scroll to zoom.

Similar companies · same sector, comparable size

Of 9,130 companies in this sector we hold annual accounts for 6,339. 350 are within a factor 10 of this headcount. The 5 above are the closest to it. See the whole sector

Company details

Identification
Legal formNon-profit association
Founded05-07-2023
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:0804242242
Also 9925:BE0804242242
Registered 11-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.